Biotech firm Medtox (MTOX -5.3%) trades lower after its Q3 missed estimates due to reduced order...


Biotech firm Medtox (MTOX -5.3%) trades lower after its Q3 missed estimates due to reduced order flow from its existing customers. EPS came in at $0.15 on sales of $27M, below analysts' expectations for an EPS of $0.17 on revenue of $28.5M.

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs